These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 7897206)

  • 1. Complement activation by cross-linked B cell-membrane IgM.
    Ohishi K; Kanoh M; Shinomiya H; Hitsumoto Y; Utsumi S
    J Immunol; 1995 Apr; 154(7):3173-9. PubMed ID: 7897206
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Membrane IgD and membrane IgM differ in capacity to transduce inhibitory signals within the same human B cell clonal populations.
    Mongini PK; Blessinger C; Posnett DN; Rudich SM
    J Immunol; 1989 Sep; 143(5):1565-74. PubMed ID: 2788188
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The ligand-induced membrane IgM association with the cytoskeletal matrix of B cells is not mediated through the Ig alpha beta heterodimer.
    Hartwig JH; Jugloff LS; De Groot NJ; Grupp SA; Jongstra-Bilen J
    J Immunol; 1995 Oct; 155(8):3769-79. PubMed ID: 7561081
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synergistic interaction between complement receptor type 2 and membrane IgM on B lymphocytes.
    Carter RH; Spycher MO; Ng YC; Hoffman R; Fearon DT
    J Immunol; 1988 Jul; 141(2):457-63. PubMed ID: 2968402
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Binding of C3 and C3dg to the CR2 complement receptor induces growth of an Epstein-Barr virus-positive human B cell line.
    Hatzfeld A; Fischer E; Levesque JP; Perrin R; Hatzfeld J; Kazatchkine MD
    J Immunol; 1988 Jan; 140(1):170-5. PubMed ID: 2826586
    [TBL] [Abstract][Full Text] [Related]  

  • 6. B cell activation. V. Differentiation signaling of B cell membrane depolarization, increased I-A expression, G0 to G1 transition, and thymidine uptake by anti-IgM and anti-IgD antibodies.
    Cambier JC; Monroe JG
    J Immunol; 1984 Aug; 133(2):576-81. PubMed ID: 6610706
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibody-independent B cell-intrinsic and -extrinsic roles for CD21/35.
    Rossbacher J; Haberman AM; Neschen S; Khalil A; Shlomchik MJ
    Eur J Immunol; 2006 Sep; 36(9):2384-93. PubMed ID: 16906534
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ligand-loaded but not free complement receptors for C3b/C4b and C3d co-cap with cross-linked B cell surface IgM and IgD.
    Tsokos GC; Thyphronitis G; Jack RM; Finkelman FD
    J Immunol; 1988 Aug; 141(4):1261-6. PubMed ID: 2969399
    [TBL] [Abstract][Full Text] [Related]  

  • 9. mIgM:mIgD ratios on B cells: mean mIgD expression exceeds mIgM by 10-fold on most splenic B cells.
    Havran WL; DiGiusto DL; Cambier JC
    J Immunol; 1984 Apr; 132(4):1712-6. PubMed ID: 6421926
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A monovalent C mu 4-specific ligand enhances the activation of human B cells by membrane IgM cross-linking ligands.
    Mongini PK; Blessinger CA; Chiorazzi N; Rajaram N; Rudich SM
    Int Immunol; 1995 Feb; 7(2):317-30. PubMed ID: 7734425
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CR2 is the primary acceptor site for C3 during alternative pathway activation of complement on human peripheral B lymphocytes.
    Marquart HV; Svehag SE; Leslie RG
    J Immunol; 1994 Jul; 153(1):307-15. PubMed ID: 7515925
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Domain-switched mouse IgM/IgG2b hybrids indicate individual roles for C mu 2, C mu 3, and C mu 4 domains in the regulation of the interaction of IgM with complement C1q.
    Chen FH; Arya SK; Rinfret A; Isenman DE; Shulman MJ; Painter RH
    J Immunol; 1997 Oct; 159(7):3354-63. PubMed ID: 9317134
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polymeric C3dg primes human B lymphocytes for proliferation induced by anti-IgM.
    Carter RH; Fearon DT
    J Immunol; 1989 Sep; 143(6):1755-60. PubMed ID: 2528579
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Membrane Ig-cytoskeletal interactions. I. Flow cytofluorometric and biochemical analysis of membrane IgM-cytoskeletal interactions.
    Albrecht DL; Noelle RJ
    J Immunol; 1988 Dec; 141(11):3915-22. PubMed ID: 3141508
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human B cell activation. Effect of T cell cytokines on the physicochemical binding requirements for achieving cell cycle progression via the membrane IgM signaling pathway.
    Mongini PK; Highet PF; Inman JK
    J Immunol; 1995 Oct; 155(7):3385-400. PubMed ID: 7561033
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Membrane IgM influences membrane IgD mediated antigen internalization in the B cell line Bcl1.
    Geisberger R; Königsberger S; Achatz G
    Immunol Lett; 2006 Feb; 102(2):169-76. PubMed ID: 16219364
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of the interaction of monoclonal antibodies with surface IgM on neoplastic B-cells.
    Cragg MS; Zhang L; French RR; Glennie MJ
    Br J Cancer; 1999 Feb; 79(5-6):850-7. PubMed ID: 10070880
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complexes between C1q and C3 or C4: novel and specific markers for classical complement pathway activation.
    Wouters D; Wiessenberg HD; Hart M; Bruins P; Voskuyl A; Daha MR; Hack CE
    J Immunol Methods; 2005 Mar; 298(1-2):35-45. PubMed ID: 15847795
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Co-ligation of ICAM-1 (CD54) and membrane IgM negatively affects B cell receptor signaling.
    van Horssen M; Loman S; Rijkers GT; Boom SE; Bloem AC
    Eur J Immunol; 1995 Jan; 25(1):154-8. PubMed ID: 7843226
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel mechanism of alternative pathway complement activation accounts for the deposition of C3 fragments on CR2-expressing homologous cells.
    Schwendinger MG; Spruth M; Schoch J; Dierich MP; Prodinger WM
    J Immunol; 1997 Jun; 158(11):5455-63. PubMed ID: 9164968
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.